UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Does Myocardial Infarction Beget Atrial Fibrillation and Atrial Fibrillation Beget Myocardial Infarction?

Circulation (New York, N.Y.), 2015-05, Vol.131 (21), p.1824-1826

2015

Volltextzugriff (PDF)

Asymptomatic persistent atrial fibrillation and outcome: Results of the RACE study

Heart rhythm, 2014-06, Vol.11 (6), p.939-945

2014

Volltextzugriff (PDF)

Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations

PloS one, 2016-11, Vol.11 (11), p.e0165828-e0165828

2016

Volltextzugriff (PDF)

Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands

Journal of the American College of Cardiology, 2015-09, Vol.66 (9), p.1000-1007

2015

Volltextzugriff (PDF)

Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study

Europace (London, England), 2014-10, Vol.16 (10), p.1417-1425

2014

Volltextzugriff (PDF)

Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality

Journal of the American College of Cardiology, 2015-09, Vol.66 (9), p.1000-1007

2015

Volltextzugriff (PDF)

Reply: Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not To Be Disregarded

Journal of the American College of Cardiology, 2016-04, Vol.67 (14), p.1754-1755

2016

Volltextzugriff (PDF)

Intravenous clusterin administration reduces myocardial infarct size in rats

European journal of clinical investigation, 2010-10, Vol.40 (10), p.893-902

2010

Volltextzugriff (PDF)

No time for change? Impact of contextual factors on the effect of training primary care healthcare workers in Kyrgyzstan and Vietnam on how to manage asthma in children - A FRESH AIR implementation study

BMC health services research, 2020-12, Vol.20 (1), p.1137-1137, Article 1137

2020

Volltextzugriff (PDF)

Inhibition of type 2A secretory phospholipase A₂ reduces death of cardiomyocytes in acute myocardial infarction

Apoptosis (London), 2009-06, Vol.14 (6), p.753-763

2009

Volltextzugriff (PDF)

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study

Netherlands heart journal, 2013-07, Vol.21 (7-8), p.354-363

2013

Volltextzugriff (PDF)

Reply

Journal of the American College of Cardiology, 2016-04, Vol.67 (14), p.1754-1755

2016

Volltextzugriff (PDF)

Reply

Journal of the American College of Cardiology, 2016, Vol.67 (14), p.1754-1755

2016

Volltextzugriff (PDF)

Fibrinogen lysine residue A alpha 157 plays a crucial role in the fibrin-induced acceleration of plasminogen activation, catalyzed by tissue-type plasminogen activator

The Journal of biological chemistry, 1987-05, Vol.262 (13), p.5944-5946

1987

Volltextzugriff (PDF)

Abstract 17473: Obesity is Associated With Impaired Left Atrial Function in Young Patients With Recent Onset Atrial Fibrillation

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A17473-A17473

2015

Volltextzugriff (PDF)

Imidazole-based ligands of the Src SH2 protein

Bioorganic & medicinal chemistry letters, 2002-05, Vol.12 (9), p.1287-1289

2002

Volltextzugriff (PDF)

Discovery of highly potent Src SH2 binders: Structure-activity studies and X-ray structures

Bioorganic & medicinal chemistry letters, 2002-05, Vol.12 (9), p.1291-1294

2002

Volltextzugriff (PDF)

Evidence for Specific sites in fibrin(ogen) that stimulate tissue activator catalyzed plasminogen activation

Structure, functional aspects, metabolism, 2019, Vol.2, p.305-314

Originally published 1983, 2019

Volltextzugriff (PDF)

Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats

Thrombosis and haemostasis, 1982-01, Vol.48 (1), p.59-61

1982

Volltextzugriff (PDF)

Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2

Biochimica et biophysica acta, 1983-02, Vol.755 (3), p.531-533

1983

Volltextzugriff (PDF)

Evidence for the localization of a calcium-binding site in the amino-terminal disulphide knot of fibrin (ogen)

Thrombosis research, 1983-07, Vol.31 (1), p.81-86

1983

Volltextzugriff (PDF)

Human fibrinogen binds edta and citrate

Thrombosis research, 1981-06, Vol.22 (5), p.659-663

1981

Volltextzugriff (PDF)

The influence of fibrin(ogen) fragments on the kinetic parameters of the tissue‐type plasminogen‐activator‐mediated activation of different forms of plasminogen

European journal of biochemistry, 1988-05, Vol.174 (1), p.163-169

1988

Volltextzugriff (PDF)

Identification of a site in fibrin(OGEN) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator

Biochimica et biophysica acta, 1983-10, Vol.748 (1), p.86-92

1983

Volltextzugriff (PDF)

The quantitative determination of apolipoprotein A-I (apo-lp-Gln I) in human serum by radial immunodiffusion assay (RID)

Clinica chimica acta, 1978-08, Vol.87 (3), p.387-394

1978

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(96)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Does Myocardial Infarction Beget Atrial Fibrillation and Atrial Fibrillation Beget Myocardial Infarction?

Asymptomatic persistent atrial fibrillation and outcome: Results of the RACE study

Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations

Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands

Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study

Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality

Reply: Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not To Be Disregarded

Intravenous clusterin administration reduces myocardial infarct size in rats

No time for change? Impact of contextual factors on the effect of training primary care healthcare workers in Kyrgyzstan and Vietnam on how to manage asthma in children - A FRESH AIR implementation study

Inhibition of type 2A secretory phospholipase A₂ reduces death of cardiomyocytes in acute myocardial infarction

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study

Reply

Reply

Fibrinogen lysine residue A alpha 157 plays a crucial role in the fibrin-induced acceleration of plasminogen activation, catalyzed by tissue-type plasminogen activator

Abstract 17473: Obesity is Associated With Impaired Left Atrial Function in Young Patients With Recent Onset Atrial Fibrillation

Imidazole-based ligands of the Src SH2 protein

Discovery of highly potent Src SH2 binders: Structure-activity studies and X-ray structures

Evidence for Specific sites in fibrin(ogen) that stimulate tissue activator catalyzed plasminogen activation

Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats

Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2

Evidence for the localization of a calcium-binding site in the amino-terminal disulphide knot of fibrin (ogen)

Human fibrinogen binds edta and citrate

The influence of fibrin(ogen) fragments on the kinetic parameters of the tissue‐type plasminogen‐activator‐mediated activation of different forms of plasminogen

Identification of a site in fibrin(OGEN) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator

The quantitative determination of apolipoprotein A-I (apo-lp-Gln I) in human serum by radial immunodiffusion assay (RID)

Suchergebnisse filtern